A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Imperial College London
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Elevation Oncology